These approaches focus on optimising medication tolerance and addressing contributing factors
In short, while theres still so much that needs sorting out, weve got a breakthrough family of drugs that are already exceeding lofty expectations
Enhanced activity of IDO enzymes (IDO-1 and IDO-2) shifts tryptophan metabolism towards the kynurenine pathway, leading to increased concentrations of kynurenic acid (KYNA) within the CNS (216220)
KPV appears to function inside cells by shutting down inflammatory pathways, including NF-kB: a powerful pro-inflammatory transcription factor that can enter the nucleus of the cell and activate inflammatory genes and cytokines such as TNF-alpha, IL-6, IL-1, and others
When glutathione levels are low, it can lead to a range of health issues
Blood 136 , 12251240 (2020)